Article
Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.
The pharmacogenomics journal - 1 Apr 2014
Bluett J, Ibrahim I, Plant D, Hyrich K L, Morgan A W, Wilson A G, Isaacs J D, Barton A
Abstract excerpt
Eligibility for anti-tumour necrosis factor (TNF) therapy in most European countries is restricted to severe, active rheumatoid arthritis (RA). The DAS28 score is a marker of disease severity and incorporates one of two inflammatory markers, erythrocyte sedimentation rate (ESR) or C-reactive protein. We aimed to determine the relation between genetic variants known to affect ESR and levels of ESR in patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.